Erwin A. Scharberg

466 total citations
27 papers, 324 citations indexed

About

Erwin A. Scharberg is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Erwin A. Scharberg has authored 27 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 19 papers in Physiology and 14 papers in Genetics. Recurrent topics in Erwin A. Scharberg's work include Blood groups and transfusion (25 papers), Erythrocyte Function and Pathophysiology (19 papers) and Blood disorders and treatments (12 papers). Erwin A. Scharberg is often cited by papers focused on Blood groups and transfusion (25 papers), Erythrocyte Function and Pathophysiology (19 papers) and Blood disorders and treatments (12 papers). Erwin A. Scharberg collaborates with scholars based in Germany, United States and United Kingdom. Erwin A. Scharberg's co-authors include Peter Bugert, Ekkehard Richter, Axel Seltsam, Jonathan H. Waters, Jay S. Raval, Marina V. Kameneva, Mark H. Yazer, Mark H. Yazer, Nicole Thornton and Vered Yahalom and has published in prestigious journals such as British Journal of Haematology, Transfusion and Vox Sanguinis.

In The Last Decade

Erwin A. Scharberg

23 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwin A. Scharberg Germany 11 216 211 92 74 50 27 324
Delores Mallory United States 12 354 1.6× 164 0.8× 91 1.0× 110 1.5× 83 1.7× 35 463
Nidal M. Irshaid Sweden 8 317 1.5× 242 1.1× 123 1.3× 24 0.3× 68 1.4× 8 358
L. D. Petz United States 10 212 1.0× 112 0.5× 28 0.3× 33 0.4× 53 1.1× 14 283
Nicoletta Revelli Italy 8 161 0.7× 105 0.5× 61 0.7× 32 0.4× 34 0.7× 24 182
Cheryl Goss United States 7 87 0.4× 23 0.1× 51 0.6× 82 1.1× 12 0.2× 15 187
J. R. Krevans United States 8 198 0.9× 79 0.4× 103 1.1× 20 0.3× 52 1.0× 11 375
Marie Tamagne France 8 125 0.6× 84 0.4× 68 0.7× 8 0.1× 20 0.4× 15 243
Hélène Savel France 6 117 0.5× 78 0.4× 23 0.3× 31 0.4× 83 1.7× 12 305
Güngör Nişli Türkiye 10 185 0.9× 24 0.1× 124 1.3× 8 0.1× 10 0.2× 23 287
A. Gorakshakar India 11 298 1.4× 54 0.3× 324 3.5× 2 0.0× 42 0.8× 19 410

Countries citing papers authored by Erwin A. Scharberg

Since Specialization
Citations

This map shows the geographic impact of Erwin A. Scharberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin A. Scharberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin A. Scharberg more than expected).

Fields of papers citing papers by Erwin A. Scharberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin A. Scharberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin A. Scharberg. The network helps show where Erwin A. Scharberg may publish in the future.

Co-authorship network of co-authors of Erwin A. Scharberg

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin A. Scharberg. A scholar is included among the top collaborators of Erwin A. Scharberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin A. Scharberg. Erwin A. Scharberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weidner, Lisa, et al.. (2025). A new blood group antigen in the Knops blood group system: KNEH. Transfusion. 65(8). 1 indexed citations
2.
Dauber, E.M., Oskar A. Haas, Karin Nebral, et al.. (2024). Body‐wide chimerism and mosaicism are predominant causes of naturally occurring ABO discrepancies. British Journal of Haematology. 205(3). 1188–1196.
3.
Weinstock, Christof, et al.. (2023). KNMB, a novel Knops blood group antigen located in LHR‐C. Transfusion. 63(11). E56–E58.
4.
Gassner, Christoph, et al.. (2022). Occurrence of Rare Deletional Yus and Gerbich Alleles in Syria and Neighbouring Countries. Transfusion Medicine and Hemotherapy. 49(6). 358–367.
5.
Scharberg, Erwin A., et al.. (2020). KDAS, a new blood group antigen in the Knops blood group system antithetical to KCAM. Transfusion. 60(8). E25–E27.
6.
Wagner, Franz F., et al.. (2020). Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe. Transfusion. 60(10). 2408–2418. 3 indexed citations
7.
Scharberg, Erwin A., et al.. (2018). Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens. Transfusion Medicine and Hemotherapy. 45(5). 331–340. 15 indexed citations
8.
Scharberg, Erwin A., et al.. (2018). The Impact of Using Genotyped Reagent Red Blood Cells in Antibody Identification. Transfusion Medicine and Hemotherapy. 45(4). 218–224. 13 indexed citations
9.
Hustinx, Hein, et al.. (2016). Rare donor programs in Switzerland, Germany, and Austria. Immunohematology. 32(2). 63–66. 4 indexed citations
10.
Scharberg, Erwin A., et al.. (2016). Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low‐prevalence Kell blood group antigen. Transfusion. 57(1). 217–218. 1 indexed citations
11.
Scharberg, Erwin A., et al.. (2016). The H blood group system. Immunohematology. 32(3). 112–118. 23 indexed citations
12.
Scharberg, Erwin A., et al.. (2015). PCR with Sequence-Specific Primers for Typing of Diallelic Blood Groups. Methods in molecular biology. 1310. 71–81. 13 indexed citations
13.
Scharberg, Erwin A., et al.. (2015). Molecular Screening for Vel- Blood Donors in Southwestern Germany. Transfusion Medicine and Hemotherapy. 42(6). 356–360. 8 indexed citations
14.
Schulze, Torsten J., et al.. (2013). Development of Anti-G, Anti-C and Anti-Jk(b) in a 22-Year-Old Mother during Her Fourth Pregnancy. Transfusion Medicine and Hemotherapy. 40(3). 207–209. 4 indexed citations
15.
Raval, Jay S., Jonathan H. Waters, Axel Seltsam, et al.. (2010). Menopausal status affects the susceptibility of stored RBCs to mechanical stress. Vox Sanguinis. 100(4). 418–421. 58 indexed citations
16.
Bugert, Peter, Erwin A. Scharberg, Christof Geisen, Inge von Zabern, & Willy A. Flegel. (2009). RhCE protein variants in Southwestern Germany detected by serologic routine testing. Transfusion. 49(9). 1793–1802. 20 indexed citations
17.
Hustinx, Hein, Joyce Poole, Peter Bugert, et al.. (2008). Molecular basis of the Rh antigen RH48 (JAL). Vox Sanguinis. 96(3). 234–239. 9 indexed citations
18.
Bugert, Peter, et al.. (2008). A Novel Variant B Allele of the ABO Blood Group Gene Associated with Lack of B Antigen Expression. Transfusion Medicine and Hemotherapy. 35(4). 9–9. 6 indexed citations
19.
Körmöczi, Günther F., Erwin A. Scharberg, & Christoph Gassner. (2008). A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis‐modifier effect of KEL3. Transfusion. 49(4). 733–739. 10 indexed citations
20.
Scharberg, Erwin A., Carole Green, Geoff Daniels, et al.. (2005). Molecular basis of the JAHK (RH53) antigen. Transfusion. 45(8). 1314–1318. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026